FDA Adverse Event Injury Summary report: N

REVI SYSTEM

MDR report key: 25200928 · Received May 18, 2026

Report

Report Number
3012239564-2026-00021
Event Type
Injury
Date Received
May 18, 2026
Date of Event
December 24, 2025
Report Date
May 12, 2026
Manufacturer
BLUEWIND MEDICAL LTD
Product Code
QXM
UDI-DI
07290017912011
PMA / PMN Number
K240037
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

BLUEWIND HAS ADOPTED MORE STRINGENT REPORTING CRITERIA FOR IMPLANT-RELATED COMPLAINTS STARTING APRIL 24, 2026. A RETROSPECTIVE REVIEW OF TWO YEARS OF COMPLAINT DATA, COVERING THE PERIOD FROM MARCH 1, 2024 TO MARCH 1, 2026, WAS PERFORMED. A TOTAL OF 543 PATIENT CASES WERE REEVALUATED. OF THESE, 68 CASES INVOLVED PATIENT INFECTION, PAIN, WOUND HEALING ISSUES, IMPLANT FAILURE, OR SURGICAL COMPLICATIONS. THESE 68 CASES WERE REASSESSED AGAINST THE UPDATED REPORTING CRITERIA FOR IMPLANT-RELATED COMPLAINTS, AND FOUR COMPLAINTS WERE DETERMINED TO BE REPORTABLE UNDER THE NEW CRITERIA. COMPLAINT 00514 IS ONE OF FOUR REPORTABLE CASES.

Description of Event or Problem · 0

THE PATIENT WAS EXPERIENCING SEVERE PAIN AT THE IMPLANT SITE AND REQUESTED EXPLANTATION OF THE DEVICE. THE PATIENT WAS ALSO DIAGNOSED WITH SEVERE VENOUS INSUFFICIENCY AND WAS LIKELY NOT AN IDEAL CANDIDATE FOR REVI.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
435297 REVI SYSTEM IMPLANTED TIBIAL ELECTRICAL URINARY, PRODUCT CODE: QXM QXM BLUEWIND MEDICAL LTD MA-1007-0600_US_CM 07290017912011

Patients

Seq Age Sex Outcome Treatment
1